SVCM

Saturn V Capital Management Portfolio holdings

AUM $545M
1-Year Est. Return 361.94%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+361.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$545M
AUM Growth
+$88.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
25
New
Increased
Reduced
Closed

Top Buys

1
+$21.9M
2
+$21.1M
3
+$16.1M
4
MNPR icon
Monopar Therapeutics
MNPR
+$13.9M
5
IMMX icon
Immix Biopharma
IMMX
+$12.3M

Top Sells

1
+$23.4M
2
+$22.7M
3
+$20.2M
4
MRUS
Merus
MRUS
+$17.3M
5
LENZ
LENZ Therapeutics
LENZ
+$17.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABVX
1
Abivax
ABVX
$8.45B
$87.5M 16.07%
649,179
-152,045
AMLX icon
2
Amylyx Pharmaceuticals
AMLX
$1.55B
$54.3M 9.97%
4,496,487
-108,391
COGT icon
3
Cogent Biosciences
COGT
$5.96B
$43.2M 7.93%
1,217,064
-807,977
JAZZ icon
4
Jazz Pharmaceuticals
JAZZ
$11.5B
$42.2M 7.74%
248,070
-52,540
PCVX icon
5
Vaxcyte
PCVX
$8.46B
$36.9M 6.77%
798,940
+10,499
DYN icon
6
Dyne Therapeutics
DYN
$2.55B
$35M 6.42%
1,788,616
-885,853
PHVS icon
7
Pharvaris
PHVS
$1.72B
$31.6M 5.81%
1,140,033
+253,701
CELC icon
8
Celcuity
CELC
$4.87B
$31.6M 5.8%
317,095
-156,733
ALMS
9
Alumis Inc
ALMS
$3.52B
$30.6M 5.62%
+3,135,953
IRON icon
10
Disc Medicine
IRON
$2.47B
$23.7M 4.35%
298,429
-42,468
XFOR icon
11
X4 Pharmaceuticals
XFOR
$288M
$23.2M 4.26%
+5,800,530
MNPR icon
12
Monopar Therapeutics
MNPR
$345M
$21.3M 3.9%
325,701
+170,331
IVVD icon
13
Invivyd
IVVD
$468M
$19.1M 3.51%
+7,735,386
OCUL icon
14
Ocular Therapeutix
OCUL
$2.35B
$18.3M 3.35%
1,504,880
+353,194
IMMX icon
15
Immix Biopharma
IMMX
$432M
$15.7M 2.88%
+2,999,169
OCS icon
16
Oculis Holding
OCS
$1.59B
$10.3M 1.89%
+516,761
IKT icon
17
Inhibikase Therapeutics
IKT
$227M
$7.91M 1.45%
+3,856,799
CNTA
18
Centessa Pharmaceuticals
CNTA
$3.77B
$7.07M 1.3%
282,692
-451,847
OVID icon
19
Ovid Therapeutics
OVID
$113M
$4.08M 0.75%
+2,500,000
IVA
20
Inventiva
IVA
$1.22B
$1.32M 0.24%
+283,166
LENZ
21
LENZ Therapeutics
LENZ
$404M
– –
-368,176
CGON icon
22
CG Oncology
CGON
$4.66B
– –
-579,895
MRUS
23
DELISTED
Merus
MRUS
– –
-184,135
NAMS icon
24
NewAmsterdam Pharma
NAMS
$3.55B
– –
-153,147
XENE icon
25
Xenon Pharmaceuticals
XENE
$3.25B
– –
-503,701